US Stock MarketDetailed Quotes

GLUE Monte Rosa Therapeutics

Watchlist
  • 3.830
  • -0.180-4.49%
Close Jun 14 16:00 ET
  • 3.830
  • 0.0000.00%
Post 16:05 ET
233.01MMarket Cap-1525P/E (TTM)

About Monte Rosa Therapeutics Company

Monte Rosa Therapeutics, Inc. operates as a biotechnology company focused on developing precision medicines. The company was founded on November 21, 2019 and is headquartered in Boston, MA.

Company Profile

SymbolGLUE
Company NameMonte Rosa Therapeutics
Listing DateJun 24, 2021
Issue Price19.00
Founded2019
CEOMr. Markus Warmuth
MarketNASDAQ
Employees133
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address321 Harrison Avenue,Suite 900
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02118
Phone1-617-949-2643
Websitehttp://www.monterosatx.com

Company Executives

  • Name
  • Position
  • Salary
  • Markus Warmuth
  • Director, Chief Executive Officer and President
  • 3.63M
  • Phil Nickson
  • Chief Business and Legal Officer
  • --
  • Dr. Filip Janku, M.D.
  • Chief Medical Officer
  • 1.49M
  • Jennifer Champoux
  • Chief Operating Officer
  • --
  • Dr. Sharon Townson, PhD
  • Chief Scientific Officer
  • --
  • Edmund Dunn
  • Principal Accounting Officer, Vice President and Corporate Controller
  • --
  • Dr. Alexander Mayweg, PhD
  • Chairman of the Board
  • 165.88K
  • Dr. Andrew N. Schiff, M.D.
  • Chairman of the Board
  • 153.38K
  • Dr. Chandra P. Leo, M.D.
  • Independent Director
  • --
  • Christine Siu
  • Independent Director
  • 150.88K
  • Dr. Kimberly L. Blackwell, M.D.
  • Independent Director
  • 140.88K
  • Dr. Jan Skvarka, PhD
  • Independent Director
  • 339.56K
  • Dr. Ali Behbahani, M.B.A.,M.D.
  • Independent Director
  • 140.88K
  • Dr. Anthony M. Manning, PhD
  • Independent Director
  • 202.10K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg